Glycolytic enzymes PGK1 and PKM2 as novel transcriptional targets of PPARγ in breast cancer pathophysiology

Author： Shashni Babita   Sakharkar Kishore R.   Nagasaki Yukio   Sakharkar Meena K.  

Publisher： Informa Healthcare

ISSN： 1061-186X

Source： Journal of Drug Targeting, Vol.21, Iss.2, 2013-02, pp. : 161-174

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential Novel Targets in Breast Cancer

By  

Current Pharmaceutical Biotechnology, Vol. 10, Iss. 2, 2009-02 ,pp. : 148-153

Bentham Science Publishers

Access to resources Recommend Favorite

Histone modification enzymes: novel targets for cancer drugs

By Kristeleit Rebecca   Stimson Lindsay   Workman Paul   Aherne Wynne  

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. : 135-154

Informa Healthcare

Access to resources Recommend Favorite

Deubiquitinating Enzymes as Therapeutic Targets in Cancer

By  

Current Pharmaceutical Design, Vol. 19, Iss. 22, 2013-07 ,pp. : 4039-4052

Bentham Science Publishers

Access to resources Recommend Favorite

Cognitive Dysfunction in Depression – Pathophysiology and Novel Targets

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 10, 2014-12 ,pp. : 1819-1835

Bentham Science Publishers

Access to resources Recommend Favorite

PPARγ disease gene network and identification of therapeutic targets for prostate cancer

By Venkatachalam Gireedhar   Kumar Alan Prem   Sakharkar Kishore R.   Thangavel Sindhu   Clement Marie-Véronique   Sakharkar Meena Kishore  

Journal of Drug Targeting, Vol. 19, Iss. 9, 2011-11 ,pp. : 781-796

Informa Healthcare

Access to resources Recommend Favorite